Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Gerstner ER"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    The Role of Antibody-Based Therapies in Neuro-Oncology.
    Autorzy:
    Ramapriyan R; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA.
    Sun J; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.
    Curry A; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.
    Richardson LG; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.
    Ramesh T; Harvard Medical School, Boston, MA 02115, USA.
    Gaffey MA; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.
    Gedeon PC; Harvard Medical School, Boston, MA 02115, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA.
    Gerstner ER; Harvard Medical School, Boston, MA 02115, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA.
    Curry WT; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA.
    Choi BD; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.; Harvard Medical School, Boston, MA 02115, USA.
    Pokaż więcej
    Źródło:
    Antibodies (Basel, Switzerland) [Antibodies (Basel)] 2023 Nov 13; Vol. 12 (4). Date of Electronic Publication: 2023 Nov 13.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.
    Autorzy:
    Ly KI; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
    Vakulenko-Lagun B; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
    Emblem KE; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
    Ou Y; Department of Pediatrics and Radiology, Boston Children's Hospital, Boston, MA, USA.
    Da X; Functional Neuroimaging Laboratory, Brigham and Women's Hospital, Boston, MA, USA.
    Betensky RA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
    Kalpathy-Cramer J; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.
    Duda DG; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
    Jain RK; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
    Chi AS; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.
    Plotkin SR; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
    Batchelor TT; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
    Sorensen G; IMRIS, Deerfield Imaging, Minnetonka, MN, USA.
    Rosen BR; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.
    Gerstner ER; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2019 Jun 14; Vol. 9 (1), pp. 8721. Date of Electronic Publication: 2019 Jun 14.
    Typ publikacji:
    Published Erratum
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI.
    Autorzy:
    Ly KI; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
    Vakulenko-Lagun B; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
    Emblem KE; Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
    Ou Y; Department of Pediatrics and Radiology, Boston Children's Hospital, Boston, MA, USA.
    Da X; Functional Neuroimaging Laboratory, Brigham and Women's Hospital, Boston, MA, USA.
    Betensky RA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
    Kalpathy-Cramer J; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.
    Duda DG; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
    Jain RK; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
    Chi AS; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, USA.
    Plotkin SR; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
    Batchelor TT; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
    Sorensen G; IMRIS, Deerfield Imaging, Minnetonka, MN, USA.
    Rosen BR; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, USA.
    Gerstner ER; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2018 Nov 20; Vol. 8 (1), pp. 17062. Date of Electronic Publication: 2018 Nov 20.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Tumor Microenvironment*
    Biomarkers/*analysis
    Chemoradiotherapy/*mortality
    Diffusion Magnetic Resonance Imaging/*methods
    Glioblastoma/*pathology
    Temozolomide/*therapeutic use
    Adult ; Aged ; Antineoplastic Agents, Alkylating/therapeutic use ; Cerebral Blood Volume ; Chemotherapy, Adjuvant ; Contrast Media ; Female ; Follow-Up Studies ; Glioblastoma/blood ; Glioblastoma/therapy ; Humans ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Survival Rate
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
    Autorzy:
    Ratai EM; Department of Radiology, Neuroradiology Division, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, United States.; A. A. Martinos Center for Biomedical Imaging, Charlestown, MA, United States of America.
    Zhang Z; Center for Statistical Sciences, Brown University, Providence, RI, United States of America.
    Fink J; Department of Radiology, University of Washington, Seattle, WA, United States of America.
    Muzi M; Department of Radiology, University of Washington, Seattle, WA, United States of America.
    Hanna L; Center for Statistical Sciences, Brown University, Providence, RI, United States of America.
    Greco E; Center for Statistical Sciences, Brown University, Providence, RI, United States of America.
    Richards T; Department of Radiology, University of Washington, Seattle, WA, United States of America.
    Kim D; Department of Radiology, Neuroradiology Division, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, United States.; A. A. Martinos Center for Biomedical Imaging, Charlestown, MA, United States of America.
    Andronesi OC; Department of Radiology, Neuroradiology Division, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, United States.; A. A. Martinos Center for Biomedical Imaging, Charlestown, MA, United States of America.
    Mintz A; Department of Radiology, Wake Forest University, Winston-Salem, NC, United States of America.
    Kostakoglu L; Department of Radiology, Mt. Sinai Medical Center, New York, NY, United States of America.
    Prah M; Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, United States of America.
    Ellingson B; Department of Radiology, UCLA Medical Center, Los Angeles, CA, United States of America.
    Schmainda K; Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, United States of America.
    Sorensen G; Department of Radiology, Neuroradiology Division, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, United States.; A. A. Martinos Center for Biomedical Imaging, Charlestown, MA, United States of America.
    Barboriak D; Department of Radiology, Duke University, Durham, NC, United States of America.
    Mankoff D; Department of Radiology, University of Pennsylvania, Philadelphia, PA, United States of America.
    Gerstner ER; A. A. Martinos Center for Biomedical Imaging, Charlestown, MA, United States of America.; Massachusetts General Hospital Cancer Center, Boston, and Harvard Medical School, MA, United States of America.
    Pokaż więcej
    Corporate Authors:
    ACRIN 6684 trial group
    Źródło:
    PloS one [PLoS One] 2018 Jun 14; Vol. 13 (6), pp. e0198548. Date of Electronic Publication: 2018 Jun 14 (Print Publication: 2018).
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
    MeSH Terms:
    Proton Magnetic Resonance Spectroscopy*
    Tumor Hypoxia*/physiology
    Brain Neoplasms/*diagnostic imaging
    Glioblastoma/*diagnostic imaging
    Aged ; Brain/diagnostic imaging ; Brain/metabolism ; Brain Neoplasms/metabolism ; Brain Neoplasms/mortality ; Brain Neoplasms/therapy ; Female ; Glioblastoma/metabolism ; Glioblastoma/mortality ; Glioblastoma/therapy ; Humans ; Imaging, Three-Dimensional ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Misonidazole/analogs & derivatives ; Positron-Emission Tomography ; Prognosis ; ROC Curve ; Radiopharmaceuticals
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies